Overview
Monkey Pox also known as mpox , a viral disease caused by the monkeypox virus a member of the orthopoxvirus family. Mpox (Monkeypox) Clade 1b refers to a specific genetic grouping of the monkeypox virus recently found in #Swedan. In recent years, as more research has been conducted and more cases have been identified worldwide, the virus has been classified into different clades (or groups) based on genetic differences. While the disease is similar to smallpox, it is generally less severe but can still cause significant illness, especially in vulnerable populations. Mpox is a viral disease that poses risks particularly in certain populations and regions.
Vaccination
- JYNNEOS (Imvamune/Imvanex):
- The JYNNEOS vaccine is the primary vaccine approved for preventing monkey pox. It is a live, non-replicating vaccine, meaning it uses a virus that cannot replicate in human cells.
- Approved for use in the U.S., Canada, and the European Union.
- Administered as two doses, 28 days apart.
- ACAM2000:
- ACAM2000 is another vaccine used to protect against mpox, but it is a live, replicating vaccine derived from the vaccinia virus.
- It is administered as a single dose by scarification (a method similar to the historical smallpox vaccine).
- Not recommended for people with weakened immune systems, skin conditions like eczema, or pregnant individuals due to higher risk of adverse effects.
Vaccine Efficacy
- Both JYNNEOS and ACAM2000 are effective at preventing monkey pox. The JYNNEOS vaccine, in particular, has been shown to provide a robust immune response with fewer side effects compared to ACAM2000.
- The vaccines are also effective at preventing other orthopoxvirus infections, including smallpox.
Who Should Get Vaccinated ?
- High-Risk Groups:
- Healthcare workers who are involved in the care of patients with confirmed or suspected mpox.
- Laboratory personnel working with orthopoxviruses.
- Individuals in communities or social networks experiencing monkey pox outbreaks.
- Post-Exposure Prophylaxis (PEP):
- Vaccination can be given after exposure to the virus to prevent the onset of the disease. The vaccine is most effective when administered within 4 days of exposure.
Side Effects
- JYNNEOS:
- Common side effects include mild pain and redness at the injection site, fatigue, headache, and muscle aches.
- Severe side effects are rare.
- ACAM2000:
- Side effects can include sore arm, fever, and more severe reactions such as myocarditis (heart inflammation) and pericarditis.
- The site of the vaccine can develop a sore that may take several weeks to heal.
Availability
- The JYNNEOS vaccine has been widely distributed in response to monkey pox outbreaks in several countries. ACAM2000 is less commonly used but is available in some stockpiles for emergency use.
Vaccine Development and History
- The JYNNEOS vaccine was initially developed to address the risk of bioterrorism involving smallpox but has since been repurposed to protect against monkey pox, given the genetic similarities between the two viruses.
Future Directions
- Ongoing research is focused on improving vaccine delivery, understanding long-term immunity, and expanding access to at-risk populations, particularly in regions where monkey pox is endemic, like Central and West Africa.
Mpox (Monkeypox) Risks, Prevention, Treatment, and Spread Control
Risks:
- Transmission:
- Human-to-Human Transmission: Mpox primarily spreads through close contact with an infected person’s skin lesions, respiratory droplets, bodily fluids, or contaminated materials like bedding.
- Animal-to-Human Transmission: The virus can also spread from animals to humans, typically through bites or scratches from infected animals, or by handling bushmeat.
- At-Risk Populations:
- Individuals in close contact with infected persons or animals.
- Healthcare workers without proper protective equipment.
- People living in or traveling to regions where mpox is endemic, such as Central and West Africa.
Prevention:
- Personal Protective Measures
- Avoid close contact with individuals who are infected or suspected to have mpox.
- Practice good hygiene, such as regular handwashing with soap and water or using an alcohol-based hand sanitizer.
- Use personal protective equipment (PPE), like gloves and masks, when caring for someone with mpox.
- Vaccination
- Pre-Exposure: Vaccination with the JYNNEOS or ACAM2000 vaccines can prevent mpox, especially in high-risk groups.
- Post-Exposure Prophylaxis (PEP): Vaccination can also be effective if given within 4 days of exposure to prevent the onset of symptoms. If given between 4-14 days after exposure, it may reduce the severity of the disease.
- Environmental Controls:
- Disinfect contaminated surfaces and materials that may carry the virus, such as bedding and clothing.
- Implement proper waste disposal practices for items that have been in contact with an infected person.
- Travel Precautions:
- Avoid contact with animals that could be carriers of the virus, particularly in regions where mpox is endemic.
- Be cautious with the consumption or handling of bushmeat.
- Symptomatic Treatment:
- Mpox is often self-limiting, and most patients recover without specific treatment. Supportive care includes managing symptoms such as fever, rash, and pain.
- Keep the skin lesions clean and dry to prevent secondary infections.
- Hospitalization:
- Severe cases may require hospitalization for supportive care, including rehydration, pain management, and treatment of complications like secondary bacterial infections.
Spread Control:
- Isolation:
- Isolate infected individuals to prevent the spread of the virus to others.
- Isolation should continue until all lesions have crusted over, fallen off, and new skin has formed.
- Contact Tracing:
- Identify and monitor people who have been in close contact with an infected person. Offer vaccination as PEP if appropriate.
- Early detection and isolation of contacts can help prevent outbreaks.
- Public Health Measures:
- Raise awareness about monkey pox symptoms, transmission, and prevention, particularly in high-risk communities.
- Implement travel restrictions or health checks during outbreaks to control the spread of the virus.
- Outbreak Response:
- While monkey pox is generally less severe than smallpox, it can cause serious complications, especially in children, pregnant women, and immunocompromised individuals.
- Complications can include secondary infections, pneumonia, encephalitis, and in some cases, death.